Feedback for Seeking Feedback on Non-Sterile Compounding Standards

Shoppers Drug Mart  ·  Nov. 18, 2016

Shoppers Drug Mart and Loblaw welcome the opportunity to comment on the NAPRA Model Standards for Pharmacy Compounding of Non Sterile Preparations.

We believe that internal operating standards, and/or training, can be used to address the majority of the proposed requirements in the Standards, and as such have no further comment on those areas.

Our main input regarding the Standards is outlined by OPA on page 6 of their response; 'OPA also asks for greater clarity and delineation between the three levels of compounding (A, B, and C), so that compounding personnel are clear on the requirements associated with them'. We fully concur with this statement, and hope that additional clarity will be provided in the final Standards

We are not aligned with requests for specific business specifications for the Master Formulation Record. Vendors/businesses have solutions/will update solutions fitting for their software solutions and the practices they support, and as such no additional direction or level of specification is required.

We fully support OPA's request for adequate time to address labeling. This is not generally an easy software fix, and requires to be built into software development cycles.

Reply or Back